What can falsely elevate B-type natriuretic peptide (BNP) levels?

Factors That Falsely Elevate BNP

The term "falsely elevated" is a misnomer—BNP elevation in non-heart-failure settings reflects genuine ventricular stress and independently predicts adverse outcomes, so these elevations should never be dismissed as false positives. 1, 2

Understanding the Mechanism

• BNP is released whenever ventricular wall tension increases—from volume overload, pressure overload, or myocardial inflammation—making it a semi-quantitative marker of cardiac stress rather than a heart-failure-specific test. 1, 3
• Any pathological process generating ventricular strain will raise BNP, whether cardiac or non-cardiac in origin. 3

Primary Cardiac Causes (Non-Heart-Failure)

Acute Coronary Syndromes

• Acute myocardial infarction produces median BNP ≈203 pg/mL versus ≈78 pg/mL in unstable angina, with levels proportional to infarct size and left-ventricular dysfunction. 4, 1
• Myocardial ischemia itself triggers BNP release independent of hemodynamic changes. 1

Structural Heart Disease

• Significant mitral regurgitation and aortic stenosis independently elevate BNP/NT-proBNP. 1
• Left-ventricular hypertrophy raises natriuretic peptides independent of filling pressures. 1, 3

Arrhythmias

• Atrial fibrillation increases BNP levels by 20–30% and reduces diagnostic accuracy for detecting heart failure; clinical-trial enrollment thresholds should be adjusted upward accordingly. 1, 3

Right-Heart Pathology

• Acute pulmonary embolism causes marked BNP elevation via right-ventricular dysfunction without left-ventricular involvement; an NT-proBNP cut-off of ≈1090 pg/mL optimizes risk stratification. 1, 3
• Primary and secondary pulmonary hypertension elevate BNP independent of left-ventricular dysfunction. 4, 1, 5

Non-Cardiac Causes

Renal Dysfunction (Most Influential)

• Chronic kidney disease (eGFR <60 mL/min/1.73 m²) produces BNP and NT-proBNP levels approximately fourfold higher than in individuals with normal renal function, even when cardiac filling pressures, cardiac index, and ejection fraction are comparable. 1, 3, 6
• The kidneys clear 55–65% of NT-proBNP versus 20–25% by the liver and 10–15% by musculoskeletal tissue, making NT-proBNP disproportionately affected by renal impairment. 1, 3
• When eGFR falls below 30 mL/min/1.73 m², the NT-proBNP/BNP ratio rises markedly. 3
• In patients <50 years with severe chronic renal failure, diagnostic NT-proBNP thresholds should be raised to >1200 pg/mL. 4, 1

Sepsis and Critical Illness

• Sepsis generates BNP/NT-proBNP concentrations comparable to acute heart failure, even without invasive hemodynamic evidence of cardiac dysfunction. 1, 3, 7
• Markedly high NT-proBNP in septic patients correlates with greater systolic cardiac dysfunction, making it difficult to separate septic cardiomyopathy from primary heart failure. 3

Endocrine Disorders

• Hyperthyroidism markedly raises NT-proBNP (mean ≈239 pg/mL) versus hypothyroidism (≈46 pg/mL) and euthyroid controls (≈56 pg/mL), with a positive correlation to free T₄ levels. 1
• Hyperaldosteronism and Cushing's syndrome are also linked to elevated NT-proBNP. 1, 3

Hepatic Disease

• Advanced liver cirrhosis with ascites is associated with higher NT-proBNP levels, likely due to volume overload and altered peptide clearance. 1, 3

Neurological Conditions

• Severe neurological insults—including subarachnoid hemorrhage, stroke, and traumatic brain injury—increase NT-proBNP concentrations via neuro-hormonal activation and direct myocardial stress. 1, 3

Anemia

• Anemia contributes to higher NT-proBNP through increased cardiac workload and compensatory mechanisms. 1, 3

Physiological Modifiers

Age

• Age >75 years is associated with chronically higher BNP independent of cardiac disease; NT-proBNP rises approximately 10–20 pg/mL per decade. 4, 1, 3
• Age-adjusted NT-proBNP thresholds for acute heart-failure diagnosis are: >450 pg/mL (<50 years), >900 pg/mL (50–75 years), and >1800 pg/mL (>75 years). 4, 8, 1

Sex

• Women exhibit BNP levels ≈80% higher and NT-proBNP ≈threefold higher than men. 1, 3

Obesity (Paradoxical Suppressor)

• Obesity (BMI ≥30 kg/m²) is associated with lower BNP and NT-proBNP values despite higher left-ventricular filling pressures, creating a diagnostic pitfall where "normal" values may mask significant cardiac pathology. 1, 3, 9
• Trial enrollment thresholds should be reduced by 20–30% in obese patients to avoid false-negative classification. 1
• The mechanism may involve reduced production, enhanced clearance, or suppression by sex-steroid hormones. 3

Critical Clinical Pitfalls

Flash Pulmonary Edema

• In flash pulmonary edema, NT-proBNP may be modestly elevated at presentation because insufficient time has elapsed for ventricular release, but levels rise markedly after treatment; repeat measurement after diuresis provides more reliable prognostic information. 1, 3

Multiple Confounders

• When advanced age, renal disease, atrial fibrillation, and obesity coexist, NT-proBNP values can exceed standard heart-failure thresholds, mandating cautious contextual interpretation. 1, 3

Prognostic Significance

• Elevated BNP in non-heart-failure settings reflects genuine ventricular stress and independently predicts mortality; such elevations should not be dismissed as "false positives." 1, 2, 10
• For each 100 pg/mL increase in BNP, the relative risk of death increases by 35% over 1.5–3 years. 4
• The risk for death associated with any given BNP level is similar between patients with and without heart failure, particularly in acute care settings. 10